{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:42:29Z","timestamp":1769586149932,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1023\/a:1018937123058","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T17:07:13Z","timestamp":1045674433000},"page":"1648-1653","source":"Crossref","is-referenced-by-count":42,"title":["Stereoselective Dissolution of Propranolol Hydrochloride from Hydroxypropyl Methylcellulose Matrices"],"prefix":"10.1007","volume":"10","author":[{"given":"Sarma P.","family":"Duddu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Vakilynejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhreddin","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J. W.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"305006_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/cen-v068n028.p009","volume":"9","author":"S. Borman","year":"1990","unstructured":"S. Borman. Chirality emerges as a key issue in pharmaceutical research. C&E News (July) 9:9\u201314 (1990).","journal-title":"C&E News"},{"key":"305006_CR2","volume-title":"Drug Stereochemistry: Analytical Methods and Pharmacology","year":"1988","unstructured":"I. W. Wainer and D. E. Drayer (eds). Drug Stereochemistry: Analytical Methods and Pharmacology, Marcel Dekker, New York, 1988."},{"key":"305006_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/chir.530010103","volume":"1","author":"W. H. De Camp","year":"1989","unstructured":"W. H. De Camp. The FDA perspective on the development of stereoisomers. Chirality\n1:2\u20136 (1989).","journal-title":"Chirality"},{"key":"305006_CR4","unstructured":"I. W. Wainer. Proceedings of Bio International '89, October 1\u20134 (1989), pp. 90\u201391."},{"key":"305006_CR5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00541922","volume":"26","author":"E. J. Ariens","year":"1984","unstructured":"E. J. Ariens. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur. J. Clin. Pharmacol.\n26:663\u2013668 (1984).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"305006_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/clpt.1986.150","volume":"40","author":"D. E. Drayer","year":"1986","unstructured":"D. E. Drayer. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview. Clin. Pharmacol. Ther.\n40:125\u2013133 (1986).","journal-title":"Clin. Pharmacol. Ther."},{"key":"305006_CR7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jps.2600780902","volume":"78","author":"F. Jamali","year":"1989","unstructured":"F. Jamali, R. Mehvar, and F. M. Pasutto. Enantioselective aspects of drug action and disposition: Therapeutic pitfalls. J. Pharm. Sci.\n78:695\u2013715 (1989).","journal-title":"J. Pharm. Sci."},{"key":"305006_CR8","volume-title":"Enantiomers, Racemates, and Resolutions","author":"J. Jacques","year":"1981","unstructured":"J. Jacques, A. Collet, and S. H. Wilen. Enantiomers, Racemates, and Resolutions, John Wiley & Sons, New York, 1981."},{"key":"305006_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1023\/A:1015851118787","volume":"7","author":"H. G. Brittain","year":"1990","unstructured":"H. G. Brittain. Crystallographic consequences of molecular dissymmetry. Pharm. Res.\n7:683\u2013689 (1990).","journal-title":"Pharm. Res."},{"key":"305006_CR10","first-page":"S-106","volume":"7","author":"S. P. Duddu","year":"1990","unstructured":"S. P. Duddu and D. J. W. Grant. Steric requirement for salt formation by ephedrine and pseudoephedrine. Pharm. Res.\n7:S-106 (1990).","journal-title":"Pharm. Res."},{"key":"305006_CR11","first-page":"S-47","volume":"6","author":"S. P. Duddu","year":"1989","unstructured":"S. P. Duddu, H.-K. Chan, and D. J. W. Grant. Crystal properties of some ephedrine salts. Pharm. Res.\n6:S-47 (1989).","journal-title":"Pharm. Res."},{"key":"305006_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02269220","volume":"9","author":"G. Hesse","year":"1976","unstructured":"G. Hesse and R. Hagel. \u00dcber inclusion-chromatographie und ein neues retentionsprinzip f\u00fcr benzolderivative. Chromatographia\n9:62\u201368 (1976).","journal-title":"Chromatographia"},{"key":"305006_CR13","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.3704640","volume":"232","author":"D. W. Armstrong","year":"1986","unstructured":"D. W. Armstrong, T. J. Ward, R. D. Armstrong, and T. E. Beesley. Separation of drug stereoisomers by the formation of \u03b2-cyclodextrin complexes. Science\n232:1132\u20131135 (1986).","journal-title":"Science"},{"key":"305006_CR14","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1248\/cpb.23.3062","volume":"23","author":"M. Kurozumi","year":"1975","unstructured":"M. Kurozumi, N. Nambu, and T. Nagai. Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with \u03b1-and \u03b2-cyclodextrins in powdered form. Chem. Pharm. Bull.\n23:3062\u20133068 (1975).","journal-title":"Chem. Pharm. Bull."},{"key":"305006_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-5173(87)90180-3","volume":"34","author":"C. Doherty","year":"1987","unstructured":"C. Doherty and P. York. Mechanisms of dissolution of frusemide\/PVP solid dispersions. Int. J. Pharm.\n34:197\u2013205 (1987).","journal-title":"Int. J. Pharm."},{"key":"305006_CR16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.2042-7158.1972.tb09097.x","volume":"24","author":"J. H. Collett","year":"1972","unstructured":"J. H. Collett, J. A. Rees, and N. A. Dickinson. Some parameters describing the dissolution rate of salicylic acid at controlled pH. J. Pharm. Pharmacol.\n24:724\u2013728 (1972).","journal-title":"J. Pharm. Pharmacol."},{"key":"305006_CR17","first-page":"S-30","volume":"8","author":"M. Piquette-Miller","year":"1991","unstructured":"M. Piquette-Miller and F. Jamali. A normal phase HPLC method for analysis of propranolol enantiomers. Pharm. Res.\n8:S-30 (1991).","journal-title":"Pharm. Res."},{"key":"305006_CR18","first-page":"428","volume-title":"Statistics","author":"J. T. McClave","year":"1988","unstructured":"J. T. McClave and F. H. Dietrich II. Statistics, Dellen, San Francisco, 1988, p. 428."},{"key":"305006_CR19","first-page":"S-192","volume":"8","author":"A. Railkar","year":"1991","unstructured":"A. Railkar, W. Phupradit, N. H. Shah, F. W. Zeng, C. I. Patel, M. H. Infeld, and A. W. Malick. Factors affecting the release kinetics from HPMC based hydrogel matrices. Pharm. Res.\n8:S-192 (1991).","journal-title":"Pharm. Res."},{"key":"305006_CR20","first-page":"77","volume-title":"Controlled Release Delivery Systems","author":"R. W. Korsmeyer","year":"1983","unstructured":"R. W. Korsmeyer and N. A. Peppas. Macromolecular and modelling aspects of swelling controlled systems. In T. J. Roseman and S. Z. Mansdorf (eds), Controlled Release Delivery Systems, Dekker, New York, 1983, pp. 77\u201390."},{"key":"305006_CR21","first-page":"110","volume":"60","author":"N. A. Peppas","year":"1985","unstructured":"N. A. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv.\n60:110\u2013111 (1985).","journal-title":"Pharm. Acta Helv."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018937123058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018937123058\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018937123058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:08:10Z","timestamp":1754028490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018937123058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["305006"],"URL":"https:\/\/doi.org\/10.1023\/a:1018937123058","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}